- 米国企業
- Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc.FULC
時価総額
$4.7億
PER
2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Collaboration revenue | - | 9 | - | 6 |
Research and development | 71 | 59 | - | 77 |
General and administrative | 13 | 21 | - | 42 |
Restructuring expenses | - | - | - | 0 |
Total operating expenses | 84 | 80 | - | 119 |
Loss from operations | -84 | -72 | - | -113 |
Other income, net | 2 | 1 | - | 3 |
Net loss | -83 | -71 | -81 | -110 |
Earnings Per Share, Basic | - | - | - | -2.44 |
Earnings Per Share, Diluted | - | - | - | -2.44 |
Net loss | -83 | -71 | -81 | -110 |
Unrealized loss on marketable securities | - | -0 | - | -0 |
Total other comprehensive loss | - | -0 | - | -0 |
Comprehensive loss | - | -71 | - | -110 |